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Abstract 
Chronic widespread pain (CWP) is common in the general population. It is unclear how people 
reporting this problem present in primary care; they may regularly consult for regional pains without 
being recognized as having a generalized condition. Our objectives were to determine the prevalence 
of people consulting in primary care for musculoskeletal conditions in different body regions on 
different occasions (recurrent regional pain consultation), the proportion with diagnosed generalized 
pain and survey-reported widespread pain, and if they have features characteristic of CWP. Phase 1 
used electronic records from 12 general practices in North Staffordshire (Consultations in Primary 
Care Archive) from 2005 to 2009. Phase 2 used linked self-reported health and primary healthcare 
data from 8,286 people aged 50 plus in eight general practices (North Staffordshire Osteoarthritis 
Project) between 2002 and 2005. In Phase 1, 11% of registered patients fulfilled criteria for recurrent 
regional pain consultation. Three-quarters had no recorded CWP-related generalized pain condition 
(e.g. fibromyalgia). In Phase 2, 53% of recurrent regional pain consulters had survey-reported 
widespread pain and 88% had consulted for somatic symptoms. Self-reported general health was 
worse in recurrent regional pain consulters than in single-region consulters, and poorest in those who 
also reported persistent widespread pain. Recurrent regional pain consulters are a heterogeneous 
group of frequent consulters sharing features with CWP (e.g. somatic symptoms) but including those 
less severely affected. They lie on the spectrum of polysymptomatic distress characteristic of CWP 
and represent a group whose needs may be better met by earlier diagnosis of multi-site pain. 
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Introduction 
Chronic widespread pain (CWP) is characterized by long-lasting pain in multiple body regions, and is 
associated with other physical symptoms such as fatigue, concentration problems, and psychological 
distress. CWP is common, with an estimated general population point prevalence of 10%.[26]  
In the American College of Rheumatology 1990 (ACR-1990) definition,[42] CWP is the fundamental 
feature of fibromyalgia, defined as pain lasting three months or longer, located axially, above and 
below the waist, and on both sides of the body. The updated definition (ACR-2010)[41] emphasizes 
additional physical symptoms (e.g. fatigue, waking unrefreshed) associated with fibromyalgia and 
placed fibromyalgia at one extreme on a spectrum of polysymptomatic distress that includes CWP. 
Due to the range of symptoms experienced and a multidisciplinary approach to treatment, it has been 
argued that fibromyalgia and CWP should be managed in primary care.[9,11,12,32,34] However, 
general practitioners (GPs) may not recognize fibromyalgia as a valid diagnosis,[1,6,22,23] may 
receive inadequate formal training in fibromyalgia,[1,7,22] and may have limited awareness of 
diagnostic criteria.[6,7,22] Most UK primary care uses Read codes to summarize patient encounters 
within electronic records.[3,35] There is no Read code for CWP, although the syndrome will be 
included in the forthcoming ICD-11 classification of disease.[8] However, whilst a code does exist for 
fibromyalgia, the disparity between its estimated community and primary care prevalences suggests 
that the label of fibromyalgia is not often used in general practice.[10,16] This may reflect the 
controversial nature of fibromyalgia and CWP, or concern about the wider implications of labeling.[2] 
Patients fulfilling CWP criteria may instead be diagnosed and treated in primary care for individual 
regional pains (for example, knee pain), rather than for a generalized pain condition.[33]  
Electronic health records (EHRs) present opportunities to study health care in large cohorts with 
many years of follow-up. However, using EHR data relies on the definition of robust clinical 
phenotypes.[14] Rohrbeck and colleagues[33] mapped the ACR-1990 CWP criteria to primary care 
consultation patterns for regional musculoskeletal complaints based on a select number of regional 
musculoskeletal pain Read codes in one general practice (Box 1). Patients identified using this 
recurrent regional pain consulter definition consulted for more health problems, and reported worse 
self-reported general health, more sleep problems, and higher levels of fatigue than controls, and 
were concluded to be potentially unrecognized as having a more generalized condition. If GPs do 
treat the condition presented at each consultation as a regional problem only, then early 
opportunities for interventions aimed at generalized pain may be missed and long-term disability 
exacerbated by incomplete management. A consultation-based CWP definition may prompt earlier 
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identification of patients and more timely management. It would also allow estimates of CWP 
prevalence, health surveillance, and monitoring of trends over time.  
Building on earlier work,[33] our objectives were to: i) determine the prevalence of recurrent regional 
pain consultation in primary care; ii) assess the extent to which such patients may be under-
recognized as having widespread pain; and iii) determine whether they share features characteristic 
of CWP. 
Methods 
The study consisted of two phases. In Phase 1 we used routinely recorded primary care data to 
investigate prevalence of recurrent consultation for regional pain conditions and determined the 
overlap with recorded non-specific generalized pain that may be related to fibromyalgia, to assess the 
extent to which widespread pain may be unrecognized in UK primary care. In Phase 2 we used linked 
survey and primary care consultation data to investigate whether patients with recurrent regional 
pain consultation have survey-reported CWP and have similar characteristics to those self-reporting 
CWP. 
Phase 1 
We used anonymized routinely collected primary care data from general practices contributing to the 
Consultations in Primary Care Archive (CiPCA) in North Staffordshire, UK. The North Staffordshire 
Research Ethics Committee gave ethical approval for the use of the CiPCA database for research 
(reference 03/04). In the UK, 98% of the population are registered with an NHS GP,[15] access to care 
is free, and GPs act as the entry point to all routine healthcare. Although North Staffordshire is more 
deprived than the average for England, the practices cover both affluent and deprived areas. Routine 
clinical data recorded by the practices are regularly audited.[30] Prevalence of musculoskeletal 
conditions in CiPCA has been demonstrated to be similar to that of larger national primary care 
consultation databases[17] and international databases.[19] We included the 12 CiPCA practices for 
which there was complete data for the years 2005–2009, with a denominator population base of 
79,796 people registered (all ages, with full registration for the five-year study period). 
We used the Read coded consultation data for this 5-year period to identify: i) patients fulfilling the 
original recurrent regional pain consultation algorithm (Box 1) based on a published list of all regional 
musculoskeletal morbidity codes (n=4,482);[20] and ii) individuals recorded with non-specific (i.e. 
with no clear established underlying diagnosis) generalized pain conditions related to CWP. These 
included fibromyalgia, fibrositis, rheumatism, myalgia, arthralgia, and polyalgia. The code lists are 
available from www.keele.ac.uk/mrr. We excluded patients without complete registration; that is, 
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those who were not registered with the same primary care practice for the full five-year period from 
2005 to 2009. 
Analysis 
We calculated the five-year recorded prevalence of recurrent regional pain consultation, fibromyalgia, 
and non-specific generalized pain, as well as the total prevalence of recurrent regional pain 
consultation or generalized pain combined. We also re-calculated total prevalence (of recurrent 
regional pain consultation or non-specific generalized pain combined) after excluding those with 
specific generalized musculoskeletal diagnoses (i.e. rheumatoid arthritis, systemic lupus 
erythematosus, polymyalgia rheumatica, ankylosing spondylitis, Sjögren’s syndrome, hypothyroidism) 
during the five-year period. The denominator population was patients registered with the CiPCA 
practices between 2005 and 2009. We directly standardized prevalence figures using the UK general 
population age and sex distribution for 2009 provided by the Office for National Statistics.  
We then calculated the percentage of recurrent regional pain consulters recorded as also consulting 
for a non-specific generalized pain complaint and the percentage of non-specific pain consulters who 
were also recurrent regional pain consulters. 
Phase 2 
The Phase 2 study population was drawn from the North Staffordshire Osteoarthritis Project 
(NorStOP), a prospective study of pain and general health of all community-dwelling adults aged 50 
years and over registered with eight general practices.[37] The North Staffordshire and Hereford and 
Worcester Research Ethics Committees granted ethical approval for the NorStOP project. We 
included those who had responded to both baseline and three-year postal health surveys from the 
three identically recruited and measured cohorts (NorStOP 1: 2002, NorStOP 2: 2003, NorStOP 3: 
2004, 2005), had consented to medical record review, and had a minimum of five years of medical 
record data available. Questionnaires were mailed with a letter from the GP practice, accompanied by 
a study information leaflet, and reminders were sent to non-responders after two and four weeks. 
GPs checked mailing lists prior to mailing to exclude unsuitable patients (for example, patients with 
terminal illnesses or dementia). Full details of the study protocol and data collection have been 
published previously.[37] 
Pain status 
We established consultation-based pain status using linked primary care medical record data for the 
five-year period starting two years prior to the baseline health questionnaire. We identified those 
fulfilling the recurrent regional pain consultation algorithm and those consulting for musculoskeletal 
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problems in a single region (recorded as consulting in just one of the three defined body regions – 
axial, upper limb, or lower limb – during the five-year study period).  
Self-reported pain status was collected by postal questionnaire at baseline and three-year follow up. 
A self-completed body manikin was used to establish the location of body pain lasting for one day or 
longer in the past four weeks. Pain diagrams have been demonstrated to be a reliable means of 
classifying widespread pain based on existing criteria.[24] ACR-1990 widespread pain was defined as 
axial pain, pain in the left and right sides of the body, and pain above and below the waist.[42] Owing 
to the limitations of the self-reported data, we were unable to ascertain chronicity using the ACR-
1990 definition of three months duration or longer. Widespread pain reported at both baseline and 
three years was therefore used as a marker of ‘persistent’ widespread pain. Self-reported widespread 
pain was classified into two categories as: 1) ACR-1990 widespread pain at baseline or three years; 
and 2) ACR-1990 widespread pain at baseline and three years (persistent widespread pain).  
General health measures 
Consultation-based measures were collected from medical records over the five-year period. These 
were: somatic symptom count, frequent attendance, and musculoskeletal and non-musculoskeletal 
consultation counts. 
CWP is often associated with additional symptoms such as fatigue and concentration problems. The 
ACR-2010 fibromyalgia definition[41] emphasizes the importance of these somatic symptoms by 
including them in the fibromyalgia case definition. We identified the number of somatic symptoms 
(e.g. fatigue, insomnia, and nausea) recorded for each patient over the five-year study period. We 
used the symptoms itemized in the ACR-2010 fibromyalgia criteria to identify corresponding Read 
codes.  
CWP patients have been found to consult more frequently than patients with no pain, independent of 
their level of psychological distress,[21] suggesting that frequent attendance is a feature of CWP. 
Research has demonstrated an association between CWP and help-seeking behavior for health 
problems.[13] We defined a frequent attender status as being in the top 10% of consulters for non-
musculoskeletal problems over the five-year period. Frequent attendance defined in this way is also 
an indirect measure of comorbidity. Non-musculoskeletal consultations were defined as primary care 
contacts recorded with any Read code (including numeric Chapters 0–9: history, examination, 
procedural and administrative codes, and Chapters A–Z: diagnostic codes) except the musculoskeletal 
codes.[20]   
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We collected self-reported health status from baseline health questionnaire responses. General 
health was assessed using the SF-12 physical health component summary score.[39] Psychological 
health was assessed using the anxiety and depression scores of the Hospital Anxiety and Depression 
Scale (HADS).[43] Cognitive impairment was measured using the alertness subscale of the Sickness 
Impact Profile (SIP).[5] Sleep was assessed by four questions, in which respondents were asked if they 
had the following sleep problems on most nights: i) trouble falling asleep; ii) waking at night; iii) 
trouble staying asleep; and iv) waking up tired. A positive response to any of the four sleep questions 
was used to indicate a reported sleep problem.  
Analysis 
We descriptively compared recurrent regional pain consulters, those who consulted for pain in a 
single region (axial, upper limb, or lower limb), and all respondents with self-reported persistent 
widespread pain by age, sex, consultation-based health measures, and self-reported health measures. 
We then determined the positive predictive values of the recurrent regional pain consultation 
definition for each of the self-reported widespread pain definitions. 
For the main analysis we compared different patterns of pain consultation with self-reported 
persistent widespread pain status (defined as having ACR-1990 widespread pain at both baseline and 
three years), by consultation-based health measures and self-reported health measures. Specifically, 
we compared the following four mutually exclusive groups of patients: A) recurrent regional pain 
consulters who also reported persistent widespread pain; B) recurrent regional pain consulters who 
did not report persistent widespread pain (but may have reported widespread pain on either baseline 
or three-year surveys); C) respondents reporting persistent widespread pain but not meeting the 
recurrent regional pain consulter definition; and D) single-region consulters not reporting persistent 
widespread pain. For this analysis, single-region consulters not reporting persistent widespread pain 
were the control (reference) group.  
We compared these four groups on frequent attendance, recording of one or more somatic 
symptoms, reporting one or more sleep problems on most nights, SF-12 physical component 
summary score, SIP cognitive impairment score, and HADS anxiety and depression scores, using 
logistic or linear regression as appropriate, and adjusting for age and sex. 
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Results 
Phase 1 
The five-year denominator (all ages) in CiPCA was 79,796. 9,172 patients fulfilled the recurrent 
regional pain consultation criteria and 6,466 patients were recorded with non-specific generalized 
pain conditions 
Prevalence 
Standardized five-year consultation prevalence ranged from 0.36% (95% confidence interval [CI] 
0.32%, 0.40%) for recorded fibromyalgia to 14.61% (95% CI 14.36%, 14.86%) for the combined 
prevalence of recurrent regional pain consultation or a code recorded for a non-specific generalized 
pain condition (Table 1). Five-year prevalence of recurrent regional pain consultation was 9.87% (95% 
CI 9.66%, 10.07%). The age and sex distribution of recurrent regional pain consultation was similar to 
that of non-specific generalized pain conditions, except that prevalence dipped slightly for non-
specific generalized pain consultation in the highest age band but continued to increase for recurrent 
regional pain consultation (Figure 1). 
Overlap of recurrent regional pain consultation with non-specific generalized pain 
Of the 6,466 patients with a record of a non-specific generalized pain condition, 290 (4%) were 
recorded with a specific fibromyalgia code. Thirty-three percent (2,106/6,466) of non-specific 
generalized consulters also fulfilled the recurrent regional pain consulter definition. The recurrent 
regional pain consultation algorithm identified 42% (123/290) of those recorded with fibromyalgia 
codes. Twenty-three percent (2,106/9,172) of recurrent regional pain consulters had a recorded non-
specific generalized pain condition.  
Phase 2 
Of 26,129 eligible participants at baseline, 71% (n=18,497) responded to the baseline health survey 
questionnaire. Of those consenting to follow-up and still registered with the GP (n=11,900), 81% 
(n=9,665) responded to the three-year follow up questionnaire. Of the 9,665 people responding to 
both baseline and three-year questionnaires, 9% (n=831) did not consent to medical record review 
and 6% (n=548) had access to less than five years of medical record data available, leaving 8,286 
participants eligible for inclusion in this study (Supplementary Figure S1).  
Incomplete responders (either baseline-only responders or baseline and three-year responders 
without five years of medical record data) showed generally small differences from the study 
population on all baseline variables assessed (Supplementary Table S1). Non-responders at baseline 
were slightly older (mean difference = 0.86 years, 95% CI 0.53, 1.18), and more likely to be male (non-
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responders: 49% male; study population: 46% male, percentage difference: 3.15%, 95% CI 1.59%, 
4.71%) than the study population.  
Of the 8,286 individuals in the study population, 85% (n=7,076) self-reported musculoskeletal pain at 
either baseline or three years. Two thousand, eight hundred and three (35%) reported ACR-1990 
widespread pain on one or both surveys, of whom 1,190 (14% of all the study population) reported 
ACR-1990 widespread pain at both baseline and three years (persistent widespread pain).  
Eighty percent (6,611/8,286) of the study population had at least one recorded musculoskeletal 
consultation in the five-year period. Twenty-two percent (n=1,786) of the population were identified 
as recurrent regional pain consulters, and 24% (n=1,979) consulted for a musculoskeletal problem in 
only one region during the five-year study period. 
Patient characteristics 
Descriptive statistics for participants with recurrent regional pain consultation and/or self-reported 
persistent widespread pain are presented in Table 2. Mean age was similar (64 to 65 years) across 
pain definitions. Sixty-four percent of patients with self-reported persistent widespread pain were 
female, which was similar to the figure of 61% observed in recurrent regional pain consulters. Eighty-
eight percent (n=1,567) of recurrent regional pain consulters had at least one recorded consultation 
for a somatic symptom, compared to 81% (n=963) of those with persistent widespread pain. In 
participants consulting for a single region, 48% were female, mean age was 64, and 62% (n=1,111) 
self-reported persistent widespread pain. 
Agreement between consultation-based and self-reported pain status 
Table 3 shows the agreement between consultation-based pain status and self-reported pain status. 
Virtually all recurrent regional pain consulters (97%, n=1,727) had self-reported pain. Fifty-three 
percent (942/1,786) of recurrent regional pain consulters reported widespread pain on one or both 
surveys, while 25% (445/1,786) reported persistent widespread pain at both baseline and three years. 
Patients recorded as consulting for single-region (axial, upper or lower limb) pain reported less 
widespread pain than recurrent regional pain consulters – with 27% (532/1,979) reporting 
widespread pain on one or both surveys, and 10% (194/1,979) reporting widespread pain at both 
baseline and three years. Recurrent regional pain consulters represented 37% (445/1,190) of those 
reporting persistent widespread pain. However, individuals from the large group who consulted with 
more than single-site musculoskeletal pain but who did not meet the definition for recurrent regional 
pain consultation (other musculoskeletal consultations) represented 40% (473/1,190) of those 
reporting persistent widespread pain. 
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The single-region controls without self-reported persistent widespread pain had the best 
consultation-based and self-reported health. The two groups of recurrent regional pain consulters 
had the most severe consultation-based health on all measures, with those also reporting persistent 
widespread pain having the worst consultation-based health (Table 4). For example, the odds of being 
a frequent attender for non-musculoskeletal conditions compared to the control group (single-region 
consulters) were: 7.07 (95% CI 5.21, 9.58) in recurrent regional pain consulters with persistent 
widespread pain; 4.99 (95% CI 3.87, 6.43) in recurrent regional pain consulters without persistent 
widespread pain; and 2.55 (95% CI 1.86, 3.48) in those with persistent widespread pain who were not 
recurrent regional pain consulters. 
Individuals both self-reporting persistent widespread pain and identified as recurrent regional pain 
consulters were the most severely affected on all self-reported health measures, followed closely by 
those with persistent widespread pain but not fulfilling the recurrent regional pain consultation 
definition. Those fulfilling the recurrent regional pain consulter definition but not reporting persistent 
widespread pain had poorer self-reported health than the control group. For example, the odds of 
reporting a sleep problem compared to the control group were: 3.07 (95% CI 2.47, 3.81) in recurrent 
regional pain consulters with persistent widespread pain; 2.97 (95% CI 2.48, 3.54) in those with 
persistent widespread pain but not recurrent regional pain consulters; and 1.42 (95% CI 1.22, 1.64) in 
recurrent regional pain consulters without persistent widespread pain. 
Discussion 
The first phase of our study determined a prevalence of recurrent regional pain consultation to 
primary care similar to estimates based on self-reported CWP in the general population.[26] Three-
quarters of recurrent regional pain consulters did not have a code recorded for generalized pain 
conditions related to CWP (e.g. fibromyalgia). They therefore had widespread pain potentially 
unrecognized as such by their GP.  
In the second phase we established some overlap between consultation-based and self-reported 
widespread pain, with half of all recurrent regional pain consulters over a five-year period self-
reporting widespread pain at least once. However, only one-quarter reported persistent widespread 
pain during this period. Conversely, only a minority of all those who self-reported CWP (37%) fulfilled 
the recurrent regional consulter definition during the five-year period. 
There were similar patterns of poor health (e.g. more somatic complaints) with recurrent regional 
pain consultation and self-reported CWP; although this was more marked for consultation measures 
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of poor health in recurrent regional pain consulters, and for survey measures in those with self-
reported CWP.  
The primary care coding prevalence of fibromyalgia was considerably lower than predicted by 
community prevalence, even accounting for a proportion of patients not consulting for their 
symptoms. This is consistent with findings from two large database studies.[10,16] The combined 
five-year prevalence of recurrent regional pain consultation (‘unrecognized’ CWP) and non-specific 
pain complaints (‘recognized’ CWP), after excluding specific generalized musculoskeletal diagnoses, 
was slightly higher, at 13%, than general population point prevalence estimates for CWP (10%).[26] 
Combined with our findings from Phase 2, this indicates that prevalence of widespread pain based on 
consultation data may give similar prevalence estimates to general population surveys based on strict 
CWP criteria, but will not represent an identical group of people. 
Recurrent regional pain consultation was more common in females and increased with age, 
consistent with that reported for CWP in the general population.[26] It was associated with more 
somatic symptoms, self-reported sleep problems and cognitive impairment, and poorer self-reported 
physical and mental health than observed in those consulting only for single-region problems. These 
are all features consistent with CWP. Somatic symptoms are a part of the ACR-2010 definition for 
fibromyalgia, including fatigue and waking unrefreshed.[41] Other research has also shown 
fibromyalgia and CWP to be associated with poor self-reported mental and physical health.[38,40] 
Recurrent regional pain consulters were more likely to be frequent attenders, which is consistent with 
research linking frequent attendance to both CWP[13,21,27] and medically unexplained 
syndromes.[31,36] However, it may also be a feature of the self-fulfilling nature of a definition that 
requires repeated consultation, although we excluded musculoskeletal conditions from our definition 
of frequent attendance.  
Half of recurrent regional pain consulters did not self-report widespread pain at either of the two 
survey points three years apart, and only a third of those self-reporting persistent widespread pain 
fulfilled the recurrent regional pain consulter definition. Fulfilling recurrent regional pain consultation 
criteria was associated with worse consultation-based health than self-reporting persistent 
widespread pain, while persistent widespread pain was associated with worse self-reported health 
than recurrent regional pain consultation. Rather than identifying all CWP patients who consult their 
GP, the recurrent regional pain consultation definition identifies a specific group of patients who may 
be unrecognized as having a generalized condition, and therefore, through their consultation 
behavior, are expressing a need that may remain unmet. This group is consequently an important 
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one, since identifying them and managing them appropriately has the potential to improve their 
health and reduce consultation demands.  
The recurrent regional pain consulter definition represents a promising phenotype for EHR studies as 
it identifies patients with non-local pain who have higher rates of disability and health care use. 
However, given the disparity between self-reported CWP and recurrent regional pain consultation, it 
is possible we should consider other approaches to developing a consultation-based definition of 
CWP, based on two observations. First, only 7% of all those with persistent widespread pain had no 
record of a musculoskeletal consultation during the study period; musculoskeletal consultation 
thereby represents a reasonable sampling frame for identifying and managing CWP in the population. 
Second, single-site musculoskeletal consultation appears to represent a low-severity group (by both 
consultation and self-report measures). Given this, it may be that systematically seeking information 
about other pain sites could be a simple way to ensure that GPs consider the extent of pain in their 
care and management of patients, and may be useful for future development of EHR-based pain 
phenotypes. The highest severity group – those with combined recurrent regional pain consultation 
and self-reported CWP – suggests that both sources of information could be useful for care and 
prevention.  
We performed this study in two large samples of patients, using high-quality primary care data and 
validated self-report instruments. The studies were limited to one area of the UK (North Staffordshire) 
and the use of an older age group in Phase 2. However, sensitivity analyses using the CiPCA data (not 
presented) demonstrated minimal differences in number of recorded somatic symptoms and 
musculoskeletal consultations between recurrent regional pain consulters from all age groups and the 
subgroup aged 45 plus. Less than a third of the eligible population (i.e. those invited to take part in 
the baseline study) was included in analyses in Phase 2, and we cannot exclude participation bias. 
However, we demonstrated that differences between the study sample and non- and partial-
responders were small.  
Not all patients with a problem will consult their GP for it; consequently, consultation prevalence will 
be lower than community population prevalence estimates. For chronic conditions, a diagnostic label 
for a repeatedly-consulted complaint may only be coded at diagnosis.[18] The use of a five-year 
period to define recurrent regional pain consultation would mean it is less likely we have missed a 
relevant diagnosis in the Phase 1 study, but it is possible some patients were recorded with 
fibromyalgia or other diagnosis outside of this period.  
We have attempted to define a relatively newly identified phenotype, a group of recurrent pain 
consulters in primary care, with a prevailing symptom of chronic musculoskeletal pain, who are 
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potentially unrecognized by their GPs as having a generalized condition associated with somatic 
symptoms. We therefore had no reference standard against which to compare the recurrent regional 
pain consulters identified by our algorithm. However, the recurrent regional pain consultation 
phenotype is closely related to fibromyalgia/CWP, and these conditions have been studied extensively 
using the ACR-1990 definition. We were able to demonstrate that recurrent regional pain consulters 
share many characteristics with CWP.  
We included 4,482 regional musculoskeletal Read codes in the definition of recurrent regional pain 
consultation based on previous consensus work. However, the codes may not always indicate 
musculoskeletal pain (e.g. unstable ankle), and the list includes codes for conditions that may not be 
appropriate for use in CWP, such as structural derangements (e.g. meniscal tears), infections, and 
inflammatory arthropathies. There may be other codes with the potential to represent 
musculoskeletal problems. Evidence of widespread pain and somatic symptoms may also be ‘hidden’ 
in the free-text of the consultation.  
Our study suggests that recurrent regional pain consulters represent a heterogeneous subgroup of 
frequent consulters, with chronic musculoskeletal problems as the prevailing symptom of their 
polysymptomatic distress, who may not be recognized as having a more generalized pain condition 
associated with somatic symptoms. They include those less severely affected, who do not necessarily 
fit established and strict CWP criteria, and therefore reflect an overlapping rather than identical group 
of persons. They nonetheless still exist on the spectrum of polysymptomatic distress characteristic of 
CWP and fibromyalgia.  
The recurrent regional pain consulter algorithm highlights the existence of a substantial group of 
patients with potentially unmet needs. Treatment focused on regional pain syndromes alone may be 
sub-optimal if the added burden of pain elsewhere in the body – and the additional characteristics 
associated with it (such as pain severity and propensity for long-term persistence) – are not identified 
and taken into account in explanation, advice and care given to the patient.[4,25] 
There is some under-recognition of CWP in primary care, implying a need for specific training for GPs. 
If some patients are not recognized as having generalized pain conditions with associated somatic 
symptoms, they may be inappropriately managed (as multiple episodes of regional pain). Ineffective 
management may lead to poor patient outcomes and contribute unnecessarily to primary care 
workload (continued consultation for unresolved symptoms). Screening for multi-site pain in patients 
presenting with single-site musculoskeletal complaints may be a simple way for GPs to consider the 
extent of pain in their management. Future research should explore this clinically important group of 
chronic consulters. Whilst there appear to be effective treatments for patients with widespread pain, 
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we do not yet understand how best to help those recurrently consulting for regional musculoskeletal 
pain. Recurrent consultation for local musculoskeletal pain offers a means of identifying a clinically 
relevant group of high users of primary care. Further research to investigate changes in their health 
over time, the financial cost of their management, and possible interventions would offer insights into 
long-term health outcomes, current economic burden and management of individuals who consult 
with non-local pain complaints. 
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Tables and figures 
Figure legends 
Box 1. The recurrent regional consulter definition.[33] 
  
 <<Insert Box 1 here>> 
 
 
Figure 1. Phase 1: Age and sex distribution for the five-year consultation prevalence of: i) recorded fibromyalgia coding; ii) recorded 
non-specific generalized pain coding; and iii) recurrent regional pain consultation for all those fully registered with the CiPCA 
practices from 2005 to 2009. 
  
 <<Insert Fig. 1 here>> 
 
NB: Y-axis scale varies between Figure i and Figures ii and iii. 
CiPCA: Consultations in Primary Care Archive. 
 
 
 
 
Table headers 
Table 1. Phase 1: Five-year prevalence of recorded pain in those registered in CiPCA practices for the full five-year period from 2005 
to 2009 (all ages). 
Table 2. Phase 2: Age, sex, consultation-based health, and self-reported health characteristics by single-region consulter, recurrent 
regional pain consulter, and self-reported CWP status (ACR-1990 at baseline and three years), age 50 years and over. 
Table 3. Phase 2: Overlap of consultation-based pain and self-reported pain status (n, row %, (column %)). 
Table 4. Phase 2: Results of logistic/linear regression analyses to compare consultation-based and self-reported health characteristics 
between recurrent regional pain consultation and self-reported persistent widespread pain status. 
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Summary 
Chronic widespread pain patients may regularly consult in primary care for regional pain without 
being recognized as having a generalized condition. 
Summary
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Box 1. The recurrent regional pain consulter definition.[33] 
In a period of 5 consecutive years, a patient fulfils all of 1–4: 
1. At least 1 consultation for a musculoskeletal complaint in the axial skeleton (neck & back); 
2. At least 1 consultation for an upper or lower limb complaint; 
3. At least 1 consultation for a regional musculoskeletal complaint in each of 3 separate years; 
4. At least 4 consultations for regional musculoskeletal complaints during the 5-year period.  
 
 
Box 1
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Female ll ul Male ll ul Total ll ul
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25-44 0.75 0.6 0.94 0.09 0.06 0.15 0.42 0.31 0.57
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Figure 1
 1 
Table 1. Phase 1: Five-year prevalence of recorded pain in those registered in CiPCA practices for the full five-year period from 2005 
to 2009 (all ages). 
  Five-year recorded prevalence % 
(95% CI) 
Consultation-based pain definition n Crude Standardized** 
Fibromyalgia 290 0.37 (0.33 to 0.42) 0.36 (0.32 to 0.40) 
Non-specific generalized pain 6,644 8.10 (7.92 to 8.29) 6.91 (6.73  to 7.08) 
Recurrent regional pain consultation 9,172 11.49 (11.27 to 11.72) 9.87 (9.66 to 10.07) 
Recurrent regional pain consultation and/or non-specific 
generalized pain 
13,532 16.96 (16.70 to 17.22) 14.61 (14.36 to 14.86) 
Recurrent regional pain consultation and/or non-specific 
generalized pain excluding specific generalized 
musculoskeletal diagnoses* 
12,364 15.49 (15.25 to 15.75) 13.44 (13.19 to 13.68) 
*Excludes any patients recorded with rheumatoid arthritis, systemic lupus erythematosus, polymyalgia rheumatica, ankylosing spondylitis, Sjögren’s 
syndrome, or hypothyroidism. 
** Directly standardized to UK general population figures for 2009, source: Office for National Statistics. 
CiPCA: Consultations in Primary Care Archive 
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Table 2. Phase 2: Age, sex, consultation-based health, and self-reported health characteristics by single-region consulter, recurrent 
regional pain consulter, and self-reported CWP status (ACR-1990 at baseline and three years), age 50 years and over. 
  Non-mutually exclusive groups 
 
Consultation-based pain 
Self-reported 
persistent 
widespread pain 
 Single-region 
consulters 
Recurrent regional 
pain consultation 
ACR-1990 baseline 
and 3 years 
Number 1,979 1,786 1,190 
Mean age (SD) 64 (9) 65 (9) 64 (9) 
Female; number (%) 959 (48) 1,084 (61) 758 (64) 
Consultation-based health    
Mean somatic symptom count (SD) 1.24 (1.41) 2.66 (2.10) 2.21 (1.99) 
One or more recorded somatic symptoms (%) 1,258 (64) 1,567 (88) 963 (81) 
Mean non-musculoskeletal consultation count (SD) 27 (20) 44 (27) 39 (25) 
Mean musculoskeletal consultation count (SD) 2 (2) 12 (8) 8 (9) 
Frequent attenders (non-musculoskeletal consultations); number (%) 101 (5) 405 (23) 209 (18) 
Self-reported mental and physical health*    
Mean (SD) SF-12 physical component summary (0 worst health–100 best health) a 44.5 (11.7) 36.8 (11.8) 31.7 (10.6) 
Mean (SD) anxiety score (0 best health–21 worst health) b 6.1 (4.0) 7.5 (4.1) 8.5 (4.4) 
Mean (SD) depression score (0 best health–21 worst health) b 3.9 (3.3) 5.2 (3.5) 6.4 (3.8) 
Mean (SD) cognitive impairment score (0 best health–100 worst health) c 10.9 (19.9) 16.1 (22.8) 21.7 (25.8) 
Number (%) reporting sleep problems on most nights** 683 (35) 818 (46) 710 (60) 
a. 12-item short form health survey – physical component summary [39]: high score = best health (scores are normalized to a general population 
mean of 50). 
b. Hospital Anxiety and Depression Scale[43]: high score = worst health 
c. Sickness Impact Profile – Alertness subscale[5]: high score = worst health 
*Data on these variables were incomplete with n ranging from: 1,550 to 1,741 for recurrent regional pain consulters, and 1,056 to 1,178 for 
persistent widespread pain. 
**Percentages calculated based on n equal to participants providing valid responses only. 
SD: Standard deviation 
CWP: Chronic widespread pain 
 
 
 
Table 2
 1 
Table 3. Phase 2: Overlap of consultation-based pain and self-reported pain status (n, row %, (column %)). 
 Primary care recorded pain  
Self-reported pain 
No recorded 
musculoskeletal 
pain 
Single-region 
musculoskeletal 
pain 
Other 
musculoskeletal 
consultations 
Recurrent regional 
pain consulters 
Total 
No self-reported pain 532 44.0% 331 27.4% 288 23.8% 59 4.9% 1,210 
(31.8%)  (16.7%)  (10.1%)  (3.3%)  (14.6%) 
Pain that is not widespread 873 20.8% 1,116 26.6% 1,429 34.0% 785 18.7% 4,203 
(52.1%)  (56.4%)  (50.2%)  (44.0%)  (50.7%) 
Non-persistent widespread 
pain (baseline or 3 years) 
192 11.4% 338 20.1% 656 39.0% 497 29.5% 1,683 
(11.5%)  (17.1%)  (23.0%)  (27.8%)  (20.3%) 
Persistent widespread pain 
(baseline and 3 years) 
78 6.6% 194 16.3% 473 39.7% 445 37.4% 1,190 
(4.7%)  (9.8%)  (16.6%)  (24.9%)  (14.4%) 
Total 1,675 20.2% 1,979 23.9% 2,846 34.3% 1,786 21.6% 8,286 
Row %s are shown in italics next to the n that they are associated with. 
Column %s are shown in brackets below the n that they are associated with. 
NB: Column %s represent positive predictive values of consultation-based definitions for self-reported pain.  
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Table 4. Phase 2: Results of logistic/linear regression analyses to compare consultation-based and self-reported health characteristics between 
recurrent regional pain consultation and self-reported persistent widespread pain status. 
 Number (%) / 
Mean (SD) 
Effect estimate 
(95% CI) 
Type of effect 
estimate 
Consultation-based    
Frequent attendancea    
Recurrent regional pain consulter and persistent widespread pain 121 (27%) 7.07 (5.21, 9.58) odds ratio* 
Recurrent regional pain consulter not persistent widespread pain 284 (21%) 4.99 (3.87, 6.43) odds ratio* 
Persistent widespread pain not recurrent regional pain consulter 88 (12%) 2.55 (1.86, 3.48) odds ratio* 
Single-region consulters not persistent self-reported widespread pain (reference) 87 (5%) reference odds ratio* 
One or more somatic symptomsb    
Recurrent regional pain consulter and persistent widespread pain 396 (89%) 4.73 (3.45, 6.47) odds ratio* 
Recurrent regional pain consulter not persistent widespread pain 1,171 (87%) 4.03 (3.34, 4.86) odds ratio* 
Persistent widespread pain not recurrent regional pain consulter 567 (76%) 1.89 (1.55, 2.30) odds ratio* 
Single-region consulters not persistent self-reported widespread pain (reference) 1,111 (62%) reference odds ratio* 
Self-reported    
Reporting of sleep problems on most nightsc    
Recurrent regional pain consulter and persistent widespread pain 269 (60%) 3.07 (2.47, 3.81) odds ratio* 
Recurrent regional pain consulter not persistent widespread pain 549 (41%) 1.42 (1.22, 1.64) odds ratio* 
Persistent widespread pain not recurrent regional pain consulter 441 (59%) 2.97 (2.48, 3.54) odds ratio* 
Single-region consulters not persistent self-reported widespread pain (reference) 573 (32%) reference odds ratio* 
SF-12 physical component summaryd    
Recurrent regional pain consulter and persistent widespread pain 30.3 (SD 9.5) -15.53 (-16.72, -14.34) mean difference** 
Recurrent regional pain consulter not persistent widespread pain 39.04 (SD 11.66) -6.42 (-7.23, -5.61) mean difference** 
Persistent widespread pain not recurrent regional pain consulter 32.62 (SD 11.08) -13.18 (-14.15, -12.21) mean difference** 
Single-region consulters not persistent self-reported widespread pain (reference) 45.69 (11.07) reference mean difference** 
HADS anxiety scoree    
Recurrent regional pain consulter and persistent widespread pain 8.8 (SD 4.2) 2.72 (2.30, 3.15) mean difference** 
Recurrent regional pain consulter not persistent widespread pain 7.03 (SD 4.00) 1.07 (0.78, 1.36) mean difference** 
Persistent widespread pain not recurrent regional pain consulter 8.38 (SD 4.44) 2.34 (1.99, 2.69) mean difference** 
Single-region consulters not persistent self-reported widespread pain (reference) 5.87 (SD 3.91) reference mean difference** 
HADS depression scoree    
Recurrent regional pain consulter and persistent widespread pain 6.6 (SD 3.6) 2.95 (2.60, 3.31) mean difference** 
Recurrent regional pain consulter not persistent widespread pain 4.68 (SD 3.33) 1.00 (0.75, 1.24) mean difference** 
Persistent widespread pain not recurrent regional pain consulter 6.31 (SD 3.96) 2.65 (2.36, 2.94) mean difference** 
Single-region consulters not persistent self-reported widespread pain (reference) 3.69 (SD 3.08) reference mean difference** 
Cognitive impairment scoref    
Recurrent regional pain consulter and persistent widespread pain 22.6 (SD 26.1) 12.79 (10.45, 15.12) mean difference** 
Recurrent regional pain consulter not persistent widespread pain 13.95 (SD 21.21) 3.99 (2.41, 5.57) mean difference** 
Persistent widespread pain not recurrent regional pain consulter 21.22 (SD 25.61) 11.46 (9.54, 13.38) mean difference** 
Single-region consulters not persistent self-reported widespread pain (reference) 9.87 (SD 19.01) reference mean difference** 
* Odds ratio calculated using logistic regression controlling for age and sex, with single-region consulters without persistent self-reported widespread pain as 
the reference group. 
** Mean difference (recurrent regional pain consulter/persistent widespread pain group minus single-region consulter not persistent widespread pain group) 
calculated using linear regression controlling for age and sex. 
a. Frequent attendance model chi2 (5) = 334.96, p<0.001 
b. One or more somatic symptoms model chi2 (5) = 373.65, p<0.001 
c. Reporting of sleep problems on most nights chi2 (5) = 246.72, p<0.001 
d.  b. 12-item short form health survey – physical component summary[39]: high score = best health 
e. Hospital Anxiety and Depression Scale[43]: high score = worst health 
f. Sickness Impact Profile – Alertness subscale[5]: high score = worst health 
SD: standard deviation. 
CI: confidence interval 
Recurrent regional pain consulter and persistent widespread pain: n = 445 
Recurrent regional pain consulter not persistent widespread pain, n = 1,341 
Persistent widespread pain not recurrent regional pain consulter, n = 745 
Single-region consulters not persistent widespread pain, n = 1,785 
 
Table 4
The RECORD statement – checklist of items, extended from the STROBE statement, which should be reported in observational studies 
using routinely collected health data. 
 
 Item 
No. 
STROBE items Location in manuscript 
where items are reported 
RECORD items Location in manuscript 
where items are 
reported 
Title and abstract  
 1 (a) Indicate the study’s design with a 
commonly used term in the title or the 
abstract (b) Provide in the abstract an 
informative and balanced summary of what 
was done and what was found 
(a) We have not indicated 
the study design in the 
abstract using a commonly 
used term, as our study 
does not neatly fit the 
description of a standard 
cohort, survey or cross-
sectional design. Our study 
consisted of two phases: i) 
Phase 1 analysed data 
collected prospectively over 
a 5-year period (cohort 
data) using a cross-sectional 
analysis; and ii) Phase 2 
used survey data from two 
time points linked to 5-years 
of prospectively collected 
electronic health record 
data and analysed it using a 
cross-sectional design. 
(b) Methods summarised in 
abstract (p2). 
RECORD 1.1: The type of data used should be 
specified in the title or abstract. When possible, the 
name of the databases used should be included. 
 
RECORD 1.2: If applicable, the geographic region 
and timeframe within which the study took place 
should be reported in the title or abstract. 
 
RECORD 1.3: If linkage between databases was 
conducted for the study, this should be clearly stated 
in the title or abstract. 
(1.1) Reference made to 
CiPCA and NorStOP 
made in abstract (p2). 
(1.2) Abstract outlines 
that both studies based 
in North Staffs, UK, and: 
i) Phase 1 study 2005 to 
2009; and ii) Phase 2 
study recruited from 
2002 to 2005 (p2). 
(1.3) Use of linkage 
between NorStOP 
survey data and 
electronic health record 
data stated in the 
abstract (p2). 
Introduction 
Background rationale 2 Explain the scientific background and 
rationale for the investigation being reported 
Scientific background and 
rationale for study is 
presented in the 
Introduction section (p3). 
  
Objectives 3 State specific objectives, including any 
prespecified hypotheses 
Specific aims of the study 
presented are in 
Introduction section (p4). 
  
Methods 
Study Design 4 Present key elements of study design early in 
the paper 
Key elements of the study 
design are introduced in the 
Introduction section of the 
paper (pp3-4) and expanded 
in the Methods section (p4). 
  
Setting 5 Describe the setting, locations, and relevant 
dates, including periods of recruitment, 
exposure, follow-up, and data collection 
Setting, locations, study 
dates are presented under 
the in the Methods section 
(pp4-5). 
  
STROBE (RECORD) Checklist
 Item 
No. 
STROBE items Location in manuscript 
where items are reported 
RECORD items Location in manuscript 
where items are 
reported 
Participants 6 (a) Cohort study - Give the eligibility 
criteria, and the sources and methods of 
selection of participants. Describe methods 
of follow-up 
Case-control study - Give the eligibility 
criteria, and the sources and methods of case 
ascertainment and control selection. Give the 
rationale for the choice of cases and controls 
Cross-sectional study - Give the eligibility 
criteria, and the sources and methods of 
selection of participants 
 
(b) Cohort study - For matched studies, give 
matching criteria and number of exposed 
and unexposed 
Case-control study - For matched studies, 
give matching criteria and the number of 
controls per case 
(a) Eligibility criteria, and 
sources and methods of 
participant selection are 
presented for Phase 1 (p4) 
and Phase 2 (p5) in the 
Methods section. 
(b) This study is not 
matched. 
RECORD 6.1: The methods of study population 
selection (such as codes or algorithms used to 
identify subjects) should be listed in detail. If this is 
not possible, an explanation should be provided.  
 
RECORD 6.2: Any validation studies of the codes or 
algorithms used to select the population should be 
referenced. If validation was conducted for this study 
and not published elsewhere, detailed methods and 
results should be provided. 
 
RECORD 6.3: If the study involved linkage of 
databases, consider use of a flow diagram or other 
graphical display to demonstrate the data linkage 
process, including the number of individuals with 
linked data at each stage. 
(6.1) A detailed 
explanation of how the 
study population for 
each phase were 
identified is presented in 
the Methods section 
(Phase 1: p4; Phase 2: 
p5). 
 
(6.2) The study aimed to 
develop and validate an 
electronic health record 
definition of pain 
consultation – part of 
this process included 
validation of the codes 
used to define 
consultation-based pain.  
 
(6.3) Phase 2 used linked 
survey and to electronic 
health record data. Full 
details have been 
published elsewhere (ref 
37). 
Variables 7 Clearly define all outcomes, exposures, 
predictors, potential confounders, and effect 
modifiers. Give diagnostic criteria, if 
applicable. 
We have defined all 
variables used including 
both consultation-based 
definitions, and self-
reported definitions in the 
methods section (pp4-7) 
 
 
RECORD 7.1: A complete list of codes and 
algorithms used to classify exposures, outcomes, 
confounders, and effect modifiers should be 
provided. If these cannot be reported, an explanation 
should be provided. 
A complete list of codes 
used to classify all 
variables is available for 
download from: 
www.keele.ac.uk/mrr an 
online clinical codes 
repository (p5). 
 
Data sources/ 
measurement 
8 For each variable of interest, give sources of 
data and details of methods of assessment 
(measurement). 
Describe comparability of assessment 
methods if there is more than one group 
Each variable used is 
identified in either the 
CiPCA dataset or NorStOP 
survey with linked electronic 
record data. A clear 
definition of all variables 
used is presented in the 
appropriate sections of the 
Methods section (pp4-7). 
Variable definitions are the 
same for different groups of 
patients.  
  
 Item 
No. 
STROBE items Location in manuscript 
where items are reported 
RECORD items Location in manuscript 
where items are 
reported 
Bias 9 Describe any efforts to address potential 
sources of bias 
Phase 1: The study 
population may not be 
representative of the UK 
population – we have 
therefore standardised 
prevalence rates to the UK 
general population. 
Phase 2: We have compared 
non-responders and 
incomplete responders to 
the study population to 
assess the possibility of 
selection bias. 
  
Study size 10 Explain how the study size was arrived at For both phases of the study 
we used all eligible 
individuals from the 
datasets used (Phase 1: p4; 
Phase 2: p5). 
 
The flow diagram presented 
in appendix Figure S1 
illustrates the creation of 
the study population and 
reasons for exclusions.  
  
Quantitative variables 11 Explain how quantitative variables were 
handled in the analyses. If applicable, 
describe which groupings were chosen, and 
why 
Methods section (Phase 1: 
p5; Phase 2: p7)  
  
 Item 
No. 
STROBE items Location in manuscript 
where items are reported 
RECORD items Location in manuscript 
where items are 
reported 
Statistical methods 12 (a) Describe all statistical methods, 
including those used to control for 
confounding 
(b) Describe any methods used to examine 
subgroups and interactions 
(c) Explain how missing data were 
addressed 
(d) Cohort study - If applicable, explain how 
loss to follow-up was addressed 
Case-control study - If applicable, explain 
how matching of cases and controls was 
addressed 
Cross-sectional study - If applicable, 
describe analytical methods taking account 
of sampling strategy 
(e) Describe any sensitivity analyses 
(a) Statistical methods used 
are presented under the 
‘Analysis’ subheadings of 
the Methods section for 
each study Phase (Phase 1: 
p5; Phase 2: p7). 
(b) N/A.  
(c) Phase 1 studies were 
based on recording of 
specific morbidity codes in 
electronic health records 
and therefore not subject to 
missing data. In Phase 2, 
responses to some survey 
items were missing, 
however, because the 
proportion of missing data 
for specific variables was a 
maximum of 13%, we 
conducted a complete case 
analysis using n equal to 
participants providing valid 
responses only. 
(d) Loss to follow-up is not 
applicable to this design we 
only included those with 
complete data 
(supplementary appendix 
Table S1 shows a 
comparison of non-
responders, incomplete 
responders and the study 
population). 
(e) N/A. 
   
Data access and 
cleaning methods 
 ..  RECORD 12.1: Authors should describe the extent to 
which the investigators had access to the database 
population used to create the study population. 
 
RECORD 12.2: Authors should provide information 
on the data cleaning methods used in the study. 
(12.1) KM had full access 
to datasets (p14) 
(12.2) Methods section 
(pp4-7). 
 Item 
No. 
STROBE items Location in manuscript 
where items are reported 
RECORD items Location in manuscript 
where items are 
reported 
Linkage  ..  RECORD 12.3: State whether the study included 
person-level, institutional-level, or other data linkage 
across two or more databases. The methods of 
linkage and methods of linkage quality evaluation 
should be provided. 
(12.3) Phase 2 included 
person-level data 
linkage. Data linkage of 
NorStOP survey data 
and electronic health 
data is documented in a 
previous publication 
cited in the paper (p5, 
ref 37). 
 
Results 
Participants 13 (a) Report the numbers of individuals at each 
stage of the study (e.g., numbers potentially 
eligible, examined for eligibility, confirmed 
eligible, included in the study, completing 
follow-up, and analysed) 
(b) Give reasons for non-participation at 
each stage. 
(c) Consider use of a flow diagram 
(a) Phase 1: N/A. 
Phase 2: The number of 
individuals at each stage of 
the study is presented in  
Figure S1 in the Appendix. 
(b) Phase 1: N/A. Phase 2: 
Reasons for exclusions at 
each stage are also 
presented in Figure S1 in 
the Appendix. 
(c) Phase 1: N/A. Phase 2: 
See Figure S1 in the 
Appendix. 
RECORD 13.1: Describe in detail the selection of the 
persons included in the study (i.e., study population 
selection) including filtering based on data quality, 
data availability and linkage. The selection of 
included persons can be described in the text and/or 
by means of the study flow diagram. 
Phase 1: N/A 
Phase 2: See Figure S1 in 
the Appendix. 
Descriptive data 14 (a) Give characteristics of study participants 
(e.g., demographic, clinical, social) and 
information on exposures and potential 
confounders 
(b) Indicate the number of participants with 
missing data for each variable of interest 
(c) Cohort study - summarise follow-up time 
(e.g., average and total amount) 
(a) Phase 1: N/A. Phase 2: 
See Table 2. 
(b) Phase 1: N/A. Phase 2: 
See Table 4 footnotes. 
(c) N/A. 
  
Outcome data 15 Cohort study - Report numbers of outcome 
events or summary measures over time 
Case-control study - Report numbers in each 
exposure category, or summary measures of 
exposure 
Cross-sectional study - Report numbers of 
outcome events or summary measures 
N/A descriptive study.   
 Item 
No. 
STROBE items Location in manuscript 
where items are reported 
RECORD items Location in manuscript 
where items are 
reported 
Main results 16 (a) Give unadjusted estimates and, if 
applicable, confounder-adjusted estimates 
and their precision (e.g., 95% confidence 
interval). Make clear which confounders 
were adjusted for and why they were 
included 
(b) Report category boundaries when 
continuous variables were categorized 
(c) If relevant, consider translating estimates 
of relative risk into absolute risk for a 
meaningful time period 
(a) N/A descriptive study. 
(b) N/A. 
(c) N/A. 
 
  
Other analyses 17 Report other analyses done—e.g., analyses 
of subgroups and interactions, and 
sensitivity analyses 
N/A.   
Discussion 
Key results 18 Summarise key results with reference to 
study objectives 
Presented at beginning of 
Discussion section (p10). 
  
Limitations 19 Discuss limitations of the study, taking into 
account sources of potential bias or 
imprecision. Discuss both direction and 
magnitude of any potential bias 
Limitations discussed in the 
Discussion section (p12-13). 
RECORD 19.1: Discuss the implications of using 
data that were not created or collected to answer the 
specific research question(s). Include discussion of 
misclassification bias, unmeasured confounding, 
missing data, and changing eligibility over time, as 
they pertain to the study being reported. 
Limitations related 
specifically to using 
routinely collected 
health data for research 
are discussed in the 
Discussion section 
(pp12-13). 
Interpretation 20 Give a cautious overall interpretation of 
results considering objectives, limitations, 
multiplicity of analyses, results from similar 
studies, and other relevant evidence 
Overall interpretation of the 
results is presented in the 
Discussion section (pp10-
12). 
  
Generalisability 21 Discuss the generalisability (external 
validity) of the study results 
Generalisability of study 
results discussed in 
Discussion section (p12). 
  
Other Information 
Funding 22 Give the source of funding and the role of 
the funders for the present study and, if 
applicable, for the original study on which 
the present article is based 
Source of funding 
acknowledged at the end of 
the manuscript under the 
‘Funding’ subheading (p14). 
  
Accessibility of 
protocol, raw data, and 
programming code 
 ..  RECORD 22.1: Authors should provide information 
on how to access any supplemental information such 
as the study protocol, raw data, or programming 
code. 
We are unable to share 
individual-level data 
(p14).  
 
*Reference: Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, Sørensen HT, von Elm E, Langan SM, the RECORD Working 
Committee.  The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement.  PLoS Medicine 2015; 
in press. 
 
*Checklist is protected under Creative Commons Attribution (CC BY) license. 
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Appendix 1 
Phase 2 – Participation bias 
 
Figure S1. Phase 2: Participation flowchart 
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Table S1. Phase 2: Descriptive comparison of responders and non-responders. Data are frequencies (%) except where indicated 
otherwise. 
 Non-responders Incomplete 
responders** 
Study population 
 (n=7,632) (n=10,211) (n=8,286) 
Female 3,883 (51) 5,834 (57) 4,477 (54) 
Age, mean (SD) 65.3 (11.7) 67.6 (10.8) 64.5 (9.1) 
Married or cohabiting* - 6,493 (65) 6,007 (72) 
Current employment* - 2,348 (24) 2,513 (30) 
Social classa *    
   High - 1,357 (13) 1,701 (21) 
   Middle - 1,471 (14) 1,546 (19) 
   Low - 6,181 (61) 4,546 (55) 
Deprivation scoreb, mean (SD)* - 12,836 (7,574) 13,953 (7,451) 
Self-reported health at baseline    
   SF-12 physical component summary (0-100)c, mean (SD)* - 40.5 (12.6) 42.4 (12.2) 
   Anxiety (0-21)d, mean (SD)* - 6.8 (4.2) 6.5 (4.1) 
   Depression (0-21)d, mean (SD)* - 5.1 (3.8) 4.3 (3.5) 
   Cognitive impairment (0-100)e, mean (SD)* - 16.3 (25.2) 12.4 (20.9) 
   Baseline self-reported pain* - 6,750 (66) 5,989 (72) 
   Baseline ACR-90 widespread pain* - 1,892 (19) 1,850 (22) 
   Baseline Manchester widespread pain* - 1,145 (11) 1,125 (14) 
a. Higher = higher managerial, higher professional or lower managerial/professional. Middle = intermediate occupations or self-employed. Lower = 
lower supervisory/technical, semi-routine or routine occupations[28]. 
b. Rank index of multiple deprivation[29] (low score = high deprivation) 
c. 12-item short form health survey – physical component summary[39] (100 best health) 
d. Hospital Anxiety and Depression Scale[43] (21 = worst health) 
e. Sickness Impact Profile – alertness subscale[5] (100 = worst health) 
SD. standard deviation 
*Data on these variables were incomplete with n values ranging from 8,456 to 10,210 for incomplete responders and 7,444 to 8,283 for the study 
population. 
** Baseline-only responders or responders to baseline and 3 years with either no consent to medical record review or access to less than 5 years of 
medical record data. 
